VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Inventory-to-Revenue : 0.00 (As of Jun. 2008)

View and export this data going back to . Start your Free Trial

What is VioQuest Pharmaceuticals Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. VioQuest Pharmaceuticals's Average Total Inventories for the quarter that ended in Jun. 2008 was $0.00 Mil. VioQuest Pharmaceuticals's Revenue for the three months ended in Jun. 2008 was $0.00 Mil.

VioQuest Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2008 stayed the same from Mar. 2008 (0.00) to Mar. 2008 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

VioQuest Pharmaceuticals Inventory-to-Revenue Historical Data

The historical data trend for VioQuest Pharmaceuticals's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VioQuest Pharmaceuticals Inventory-to-Revenue Chart

VioQuest Pharmaceuticals Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Inventory-to-Revenue

Get a 7-Day Free Trial

0.08

0.15

0.10

VioQuest Pharmaceuticals Quarterly Data
	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of VioQuest Pharmaceuticals's Inventory-to-Revenue

For the Biotechnology subindustry, VioQuest Pharmaceuticals's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VioQuest Pharmaceuticals's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VioQuest Pharmaceuticals's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where VioQuest Pharmaceuticals's Inventory-to-Revenue falls into.

VioQuest Pharmaceuticals Inventory-to-Revenue Calculation

VioQuest Pharmaceuticals's Inventory-to-Revenue for the fiscal year that ended in Dec. 2007 is calculated as

	Inventory-to-Revenue (A: Dec. 2007 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2006 )	+	Total Inventories (A: Dec. 2007 ))	/	count )	/	Revenue (A: Dec. 2007 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

VioQuest Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2008 is calculated as

	Inventory-to-Revenue (Q: Jun. 2008 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Mar. 2008 )	+	Total Inventories (Q: Jun. 2008 ))	/	count )	/	Revenue (Q: Jun. 2008 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

VioQuest Pharmaceuticals (OTCPK:VOQP) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

VioQuest Pharmaceuticals's Days Inventory for the three months ended in Jun. 2008 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2008 )	/	Cost of Goods Sold (Q: Jun. 2008 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

VioQuest Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2008 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2008 )	/	Average Total Inventories (Q: Jun. 2008 )
	=	0	/	0
	=

VioQuest Pharmaceuticals Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of VioQuest Pharmaceuticals's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VioQuest Pharmaceuticals Inc (OTCPK:VOQP) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 2287, Minneapolis, MN, USA, 55402

Website

VioQuest Pharmaceuticals Inc is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer and side effects of cancer treatment.

Executives

Mark D Dacko	director, officer: CFO and Secretary	800 NICOLLET MALL SUITE 2690, MINNEAPOLIS MN 55402
Christopher P. Schnittker	officer: V.P. & Chief Financial Officer	29 EMMONS DRIVE, SUITE C-10, PRINCETON NJ 08540
Brian Lenz	officer: CFO and Treasurer	65 COMMERCE WAY, HACKENSACK NJ 07601
Lau Johnson Yiu Nam	director
Michael Weiser	director	C/O SPACES, SUITE 265, 3350 VIRGINIA STREET, MIAMI FL 33133
Stephen Rocamboli	director, officer: Secretary	C/OPARMOUNT CAPITAL, 787 SEVENTH AVE 48TH FL, NEW YORK NY 10019
Daniel E Greenleaf	director, officer: President and CEO	C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Lester E Lipschutz	10 percent owner	WOLF BLOCK SCHORR AND SOLIS COHEN, 1650 ARCH STREET, PHILADELPHIA PA 19103
David M Tanen	director	TWO RIVER GROUP HOLDINGS, LLC., 689 FIFTH AVENUE, NEW YORK NY 10022

VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Headlines

No Headlines